Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE4.2000
- TODAY'S CHANGE (%)-0.4000 (-8.6957%)
- Bid / Lots4.1900/ 90
- Ask / Lots4.2900/ 13
- Open / Previous Close4.6000 / 4.6000
- Day Range
- 52 Week Range
- Volume2,626,259
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 60494 | 4.58 |
| 09:34 ET | 2950 | 4.67 |
| 09:36 ET | 2115 | 4.58 |
| 09:38 ET | 2498 | 4.6 |
| 09:39 ET | 3377 | 4.61 |
| 09:41 ET | 4324 | 4.5824 |
| 09:43 ET | 12508 | 4.61 |
| 09:45 ET | 29641 | 4.63 |
| 09:48 ET | 4575 | 4.56 |
| 09:50 ET | 1916 | 4.5 |
| 09:52 ET | 3865 | 4.52 |
| 09:54 ET | 15218 | 4.515 |
| 09:56 ET | 4318 | 4.55 |
| 09:57 ET | 4232 | 4.56 |
| 09:59 ET | 11516 | 4.5084 |
| 10:01 ET | 5789 | 4.47 |
| 10:03 ET | 1666 | 4.5 |
| 10:06 ET | 14853 | 4.51 |
| 10:08 ET | 8217 | 4.41 |
| 10:10 ET | 4474 | 4.37 |
| 10:12 ET | 7460 | 4.39 |
| 10:14 ET | 3700 | 4.38 |
| 10:15 ET | 4602 | 4.36 |
| 10:17 ET | 27363 | 4.4 |
| 10:19 ET | 107482 | 4.38 |
| 10:21 ET | 13506 | 4.38 |
| 10:24 ET | 19370 | 4.395 |
| 10:26 ET | 1034 | 4.38 |
| 10:28 ET | 4718 | 4.36 |
| 10:30 ET | 4204 | 4.34 |
| 10:32 ET | 4379 | 4.3378 |
| 10:33 ET | 1477 | 4.35 |
| 10:35 ET | 12532 | 4.36 |
| 10:37 ET | 1500 | 4.36 |
| 10:39 ET | 5506 | 4.34 |
| 10:42 ET | 3100 | 4.32 |
| 10:44 ET | 19768 | 4.34 |
| 10:46 ET | 4156 | 4.34 |
| 10:48 ET | 8073 | 4.35 |
| 10:50 ET | 4708 | 4.36 |
| 10:51 ET | 9108 | 4.35 |
| 10:53 ET | 1471 | 4.34 |
| 10:55 ET | 362 | 4.33 |
| 10:57 ET | 1560 | 4.34 |
| 11:00 ET | 2246 | 4.34 |
| 11:02 ET | 804 | 4.34 |
| 11:04 ET | 16733 | 4.3 |
| 11:06 ET | 3168 | 4.3015 |
| 11:08 ET | 2240 | 4.31 |
| 11:09 ET | 1100 | 4.3 |
| 11:11 ET | 2293 | 4.31 |
| 11:13 ET | 3576 | 4.29 |
| 11:15 ET | 4058 | 4.28 |
| 11:18 ET | 2771 | 4.28 |
| 11:20 ET | 400 | 4.28 |
| 11:22 ET | 7225 | 4.29 |
| 11:24 ET | 1612 | 4.31 |
| 11:26 ET | 1591 | 4.3 |
| 11:27 ET | 852 | 4.31 |
| 11:29 ET | 871 | 4.3043 |
| 11:31 ET | 11271 | 4.31 |
| 11:33 ET | 400 | 4.31 |
| 11:36 ET | 2170 | 4.31 |
| 11:38 ET | 1167 | 4.3 |
| 11:40 ET | 2496 | 4.31 |
| 11:42 ET | 12669 | 4.31 |
| 11:44 ET | 1228 | 4.285 |
| 11:45 ET | 2853 | 4.28 |
| 11:47 ET | 6285 | 4.295 |
| 11:49 ET | 1868 | 4.3 |
| 11:51 ET | 1400 | 4.3 |
| 11:54 ET | 2620 | 4.285 |
| 11:56 ET | 3961 | 4.28 |
| 11:58 ET | 15790 | 4.27 |
| 12:00 ET | 7168 | 4.26 |
| 12:02 ET | 2304 | 4.25 |
| 12:03 ET | 8372 | 4.26 |
| 12:05 ET | 13292 | 4.28 |
| 12:07 ET | 9494 | 4.28 |
| 12:09 ET | 120997 | 4.41 |
| 12:12 ET | 8250 | 4.43 |
| 12:14 ET | 21269 | 4.41 |
| 12:16 ET | 1980 | 4.39 |
| 12:18 ET | 4873 | 4.3899 |
| 12:20 ET | 1470 | 4.37 |
| 12:21 ET | 7031 | 4.38 |
| 12:23 ET | 4004 | 4.35 |
| 12:25 ET | 1591 | 4.37 |
| 12:27 ET | 1775 | 4.38 |
| 12:30 ET | 4000 | 4.37 |
| 12:32 ET | 5682 | 4.365 |
| 12:34 ET | 600 | 4.36 |
| 12:36 ET | 1134 | 4.35 |
| 12:38 ET | 6913 | 4.33 |
| 12:39 ET | 5152 | 4.32 |
| 12:41 ET | 2560 | 4.3 |
| 12:43 ET | 2478 | 4.3 |
| 12:45 ET | 3400 | 4.31 |
| 12:48 ET | 1570 | 4.32 |
| 12:50 ET | 3346 | 4.33 |
| 12:52 ET | 1000 | 4.33 |
| 12:54 ET | 5446 | 4.33 |
| 12:56 ET | 1806 | 4.31 |
| 12:57 ET | 4098 | 4.33 |
| 12:59 ET | 1986 | 4.32 |
| 01:01 ET | 1100 | 4.32 |
| 01:03 ET | 555 | 4.31 |
| 01:06 ET | 5086 | 4.32 |
| 01:08 ET | 967 | 4.32 |
| 01:10 ET | 5315 | 4.3 |
| 01:12 ET | 8105 | 4.28 |
| 01:14 ET | 4132 | 4.29 |
| 01:15 ET | 2097 | 4.295 |
| 01:17 ET | 524 | 4.29 |
| 01:19 ET | 3971 | 4.28 |
| 01:21 ET | 800 | 4.28 |
| 01:24 ET | 2322 | 4.275 |
| 01:26 ET | 300 | 4.275 |
| 01:28 ET | 3510 | 4.28 |
| 01:30 ET | 2436 | 4.27 |
| 01:32 ET | 4184 | 4.28 |
| 01:33 ET | 1400 | 4.26 |
| 01:35 ET | 32778 | 4.225 |
| 01:37 ET | 3119 | 4.22 |
| 01:39 ET | 982 | 4.23 |
| 01:42 ET | 1629 | 4.2 |
| 01:44 ET | 3969 | 4.2304 |
| 01:46 ET | 8523 | 4.25 |
| 01:48 ET | 700 | 4.25 |
| 01:50 ET | 3692 | 4.25 |
| 01:51 ET | 720 | 4.25 |
| 01:53 ET | 2157 | 4.25 |
| 01:55 ET | 2800 | 4.26 |
| 01:57 ET | 300 | 4.26 |
| 02:00 ET | 6608 | 4.26 |
| 02:02 ET | 2063 | 4.27 |
| 02:04 ET | 3550 | 4.27 |
| 02:06 ET | 2599 | 4.26 |
| 02:08 ET | 3851 | 4.27 |
| 02:09 ET | 700 | 4.26 |
| 02:11 ET | 1400 | 4.26 |
| 02:13 ET | 2000 | 4.27 |
| 02:15 ET | 1700 | 4.26 |
| 02:18 ET | 2609 | 4.26 |
| 02:20 ET | 800 | 4.26 |
| 02:22 ET | 3584 | 4.26 |
| 02:24 ET | 5125 | 4.27 |
| 02:26 ET | 850 | 4.26 |
| 02:27 ET | 2102 | 4.24 |
| 02:29 ET | 700 | 4.25 |
| 02:31 ET | 3852 | 4.21 |
| 02:33 ET | 300 | 4.21 |
| 02:36 ET | 5411 | 4.21 |
| 02:38 ET | 20596 | 4.22 |
| 02:40 ET | 8561 | 4.23 |
| 02:42 ET | 2900 | 4.25 |
| 02:44 ET | 400 | 4.2489 |
| 02:45 ET | 2529 | 4.23 |
| 02:47 ET | 2924 | 4.235 |
| 02:49 ET | 3923 | 4.24 |
| 02:51 ET | 200 | 4.24 |
| 02:54 ET | 10185 | 4.245 |
| 02:56 ET | 2187 | 4.245 |
| 02:58 ET | 4688 | 4.24 |
| 03:00 ET | 3373 | 4.25 |
| 03:02 ET | 49606 | 4.25 |
| 03:03 ET | 1000 | 4.25 |
| 03:05 ET | 950 | 4.25 |
| 03:07 ET | 3867 | 4.26 |
| 03:09 ET | 2825 | 4.25 |
| 03:12 ET | 2737 | 4.25 |
| 03:14 ET | 1900 | 4.25 |
| 03:16 ET | 7922 | 4.28 |
| 03:18 ET | 1403 | 4.28 |
| 03:20 ET | 5686 | 4.27 |
| 03:21 ET | 500 | 4.27 |
| 03:23 ET | 4008 | 4.26 |
| 03:25 ET | 6513 | 4.26 |
| 03:27 ET | 4909 | 4.25 |
| 03:30 ET | 17720 | 4.26 |
| 03:32 ET | 500 | 4.25 |
| 03:34 ET | 8807 | 4.26 |
| 03:36 ET | 2993 | 4.25 |
| 03:38 ET | 2455 | 4.25 |
| 03:39 ET | 3910 | 4.25 |
| 03:41 ET | 19669 | 4.25 |
| 03:43 ET | 9251 | 4.25 |
| 03:45 ET | 57881 | 4.225 |
| 03:48 ET | 82968 | 4.17 |
| 03:50 ET | 7802 | 4.165 |
| 03:52 ET | 26881 | 4.13 |
| 03:54 ET | 25021 | 4.145 |
| 03:56 ET | 42103 | 4.165 |
| 03:57 ET | 32978 | 4.165 |
| 03:59 ET | 436049 | 4.2 |
Jun 24, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 3:56PM ET on Monday Jun 24, 2024 by Dow Jones
3:56PM ET on Monday Jun 24, 2024 by Dow Jones
Jun 21, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 5:20PM ET on Friday Jun 21, 2024 by Dow Jones
5:20PM ET on Friday Jun 21, 2024 by Dow Jones
Jun 20, 2024
DJ Zentalis Pharmaceuticals Cut to Neutral From Buy by UBS, from 12:46PM ET on Thursday Jun 20, 2024 by Dow Jones
12:46PM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 18, 2024
DJ Zentalis Pharmaceuticals Cut to Equal-Weight From Overweight by Wells Fargo, from 6:10PM ET on Tuesday Jun 18, 2024 by Dow Jones
6:10PM ET on Tuesday Jun 18, 2024 by Dow JonesDJ Zentalis Pharmaceuticals Is Maintained at Buy by Stifel, from 1:45PM ET on Tuesday Jun 18, 2024 by Dow Jones
1:45PM ET on Tuesday Jun 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 326.7M | -1.3x | --- |
Korro Bio Inc | 325.6M | -0.8x | --- |
Kyverna Therapeutics Inc | 340.2M | -4.5x | --- |
ALX Oncology Holdings Inc | 341.3M | -1.8x | --- |
Aura Biosciences Inc | 352.3M | -3.7x | --- |
Anavex Life Sciences Corp | 356.3M | -8.2x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Executive Director
- Cam Gallagher
- Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Financial Officer, Treasurer
- Melissa Epperly
- Chief Operating Officer
- Iris Roth
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $326.7M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-3.36 |
Book Value | $6.18 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 8.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -639.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
